[Differences in cerebral glucose metabolism between frontotemporal lobar degeneration and Alzheimer's disease]

Psychiatr Prax. 2004 Nov:31 Suppl 1:S73-5. doi: 10.1055/s-2004-828411.
[Article in German]

Abstract

Objective: To describe differences in cerebral glucose metabolism between frontotemporal lobar degeneration (FTLD) and Alzheimer's disease (AD).

Methods: 14 patients with FTLD (7 f/7 m, mean age 60.1 years) and 14 patients with AD (7 f/7 m, mean age 59.5 years) were examined. [18F]FDG positron emission tomography (PET) scans were analysed with statistical nonparametric mapping (SnPM) and statistical parametric mapping (SPM99).

Results: Significant decreases in glucose metabolism in FTLD compared to AD were detected in the left insula/left inferior frontal gyrus (Brodman area [BA]13, 45 and 47) and in the medial frontal gyrus bilaterally (BA10). A significant decrease in AD compared to FTLD was identified in the right middle temporal gyrus (BA39).

Conclusion: Cerebral PET could be a promising tool to discriminate FTLD from AD.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Alzheimer Disease / diagnostic imaging*
  • Blood Glucose / metabolism*
  • Cerebral Cortex / diagnostic imaging*
  • Dementia / diagnostic imaging*
  • Diagnosis, Differential
  • Dominance, Cerebral / physiology
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Middle Aged
  • Positron-Emission Tomography*
  • Reference Values

Substances

  • Blood Glucose
  • Fluorodeoxyglucose F18